gastric emptying glp 1 GLP-1 Medicines And Gut Bacterial Overgrowth GLP-1 receptor agonists and delayed

Review and Verification : Before submission, double-check all entries for accuracy and completeness to prevent delays in processing

Always discuss your complete medical history, including gallbladder removal, with your healthcare provider when considering Wegovy treatment to ensure personalised care and optimal results

The risk of developing these severe side effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms. An estimated 1.6 million UK adults used GLP-1s such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) to lose weight between early 2024 and early 2025, with an additional 3.3 million interested in using weight loss drugs during 2026

Shen J, Cookson MR